Atossa Therapeutics to Release Final Data from Phase 2 Study of Endoxifen Administered to Breast Cancer Patients Prior to Surgery at a Webinar at 8 am Pacific Time on June 9, 2021GlobeNewsWire • 06/07/21
New Research Demonstrates Claims that the Wuhan Institute of Virology had no cases of COVID-19 are not crediblePRNewsWire • 05/27/21
Physician-Scientist Dr. Steven Quay to Brief the U.S. Congress On His Research Investigating the Origin of the COVID-19 PandemicPRNewsWire • 05/21/21
Atossa Therapeutics Announces First Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/14/21
Atossa Therapeutics to Participate at the Investor Summit Conference and Present to Investors on May 18, 2021GlobeNewsWire • 05/14/21
Atossa Therapeutics Urges Shareholders to Vote on Proposals Ahead of its Annual Stockholder Meeting May 14, 2021 at 1:00 PM Pacific TimeGlobeNewsWire • 05/11/21
Atossa Therapeutics CEO Dr. Steven Quay to Participate in Panel Discussion at Cello Health's Cancer Progress Virtual Conference on May 6, 2021GlobeNewsWire • 04/30/21
Atossa Therapeutics Announces Ovarian Cancer Patient has Begun Treatment with Oral Endoxifen under FDA's Expanded Access PathwayGlobeNewsWire • 04/08/21
Atossa Therapeutics Announces Year End 2020 Financial Results and Provides Corporate UpdateGlobeNewsWire • 03/31/21
Physician-Scientist Steven Quay Provides Open Letter Response to WHO Report: Five Undisputed Facts Support the Laboratory Origin of the COVID VirusPRNewsWire • 03/30/21